Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00JNH
|
||||
Former ID |
DNC000462
|
||||
Drug Name |
Conantokins G
|
||||
Indication | Discovery agent | Investigative | [535659] | ||
Formula |
C88H138N26O44
|
||||
CAS Number |
CAS 93438-65-4
|
||||
Target and Pathway | |||||
Target(s) | Glutamate [NMDA] receptor subunit epsilon 2 | Target Info | Antagonist | [535659] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Circadian entrainment | |||||
Long-term potentiation | |||||
Glutamatergic synapse | |||||
Dopaminergic synapse | |||||
Alzheimer's disease | |||||
Amyotrophic lateral sclerosis (ALS) | |||||
Huntington's disease | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Nicotine addiction | |||||
Alcoholism | |||||
Systemic lupus erythematosus | |||||
Pathway Interaction Database | ErbB4 signaling events | ||||
Reelin signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.